This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Ari Elizabeth Ericson: Innovator in Pharmaceutical Synthesis
Introduction
Ari Elizabeth Ericson is a notable inventor based in Moorpark, California. She has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of innovative synthetic methods.
Latest Patents
Ari holds a patent for the "Synthesis of omecamtiv mecarbil." This patent details synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride. Her work in this area demonstrates her expertise and commitment to advancing medical science.
Career Highlights
Ari is currently employed at Amgen Inc., a leading biotechnology company. Her role at Amgen allows her to apply her innovative ideas and contribute to the development of groundbreaking therapies.
Collaborations
Throughout her career, Ari has collaborated with esteemed colleagues, including Sebastien Caille and James Murray. These partnerships have further enhanced her research and development efforts.
Conclusion
Ari Elizabeth Ericson is a pioneering inventor whose work in pharmaceutical synthesis is making a significant impact in the medical field. Her contributions, particularly in the synthesis of omecamtiv mecarbil, highlight her role as an innovator in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile